Quite a few patients affected by hidradenitis suppurativa/acne inversa suffer from disease manifestations long before targeted therapeutic measures are taken. There are various reasons for this. One approach to tackling the problem of diagnostic latency is to increase awareness and improve interdisciplinary networking. The evidence base and treatment options have expanded considerably in recent times. In the case of biologics, there are now several active substances to choose from and there have also been some innovations in antibiotics.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Prurigo nodularis
Retrospective analyses of large data sets from everyday practice
- Public Health
Outpatient care in Switzerland: situation report
- Practice Management
Improved quality of care aims for satisfied patients
- Chemsex - MSM, sex, chrystal meth & co.
Medical and psychosocial perspectives
- Bladder cancer
Tuberculosis vaccination reduces recurrences
- Oral JAK-i in atopic dermatitis
Benefits and risks: What does the current data say?
- Chronic lung diseases
Sarcopenia and malnutrition in the context of pneumological rehabilitation
- Sleep-wake disorders in pneumology practice